Uni-Bio Science Group Limited (0690.HK)
HKD 0.08
(2.67%)
HKD 0.08
(2.67%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 409.99 Million HKD | 40.18% |
| 2022 | 292.47 Million HKD | 9.3% |
| 2021 | 267.59 Million HKD | 5.89% |
| 2020 | 252.71 Million HKD | -14.75% |
| 2019 | 296.45 Million HKD | 22.27% |
| 2018 | 242.44 Million HKD | -37.86% |
| 2017 | 390.18 Million HKD | -21.54% |
| 2016 | 497.32 Million HKD | -10.71% |
| 2015 | 556.95 Million HKD | -6.66% |
| 2014 | 596.66 Million HKD | -13.89% |
| 2013 | 692.91 Million HKD | -20.71% |
| 2012 | 873.93 Million HKD | -2.54% |
| 2011 | 896.69 Million HKD | -2.73% |
| 2010 | 921.83 Million HKD | -17.02% |
| 2009 | 1.11 Billion HKD | -23.26% |
| 2008 | 1.44 Billion HKD | -22.42% |
| 2007 | 1.86 Billion HKD | 43.6% |
| 2006 | 1.29 Billion HKD | 836.14% |
| 2005 | 138.8 Million HKD | -24.2% |
| 2004 | 183.11 Million HKD | -13.91% |
| 2003 | 212.7 Million HKD | 0.35% |
| 2002 | 211.96 Million HKD | 18.1% |
| 2001 | 179.47 Million HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 487.08 Million HKD | 0.0% |
| 2024 Q1 | 487.08 Million HKD | 18.8% |
| 2023 Q1 | 311.28 Million HKD | 6.43% |
| 2023 Q3 | 409.99 Million HKD | 31.71% |
| 2023 Q2 | 311.28 Million HKD | 0.0% |
| 2023 Q4 | 409.99 Million HKD | 0.0% |
| 2023 FY | 409.99 Million HKD | 40.18% |
| 2022 Q1 | 262.47 Million HKD | -1.91% |
| 2022 Q3 | 292.47 Million HKD | 11.43% |
| 2022 FY | 292.47 Million HKD | 9.3% |
| 2022 Q4 | 292.47 Million HKD | 0.0% |
| 2022 Q2 | 262.47 Million HKD | 0.0% |
| 2021 Q4 | 267.59 Million HKD | 0.0% |
| 2021 FY | 267.59 Million HKD | 5.89% |
| 2021 Q1 | 287.74 Million HKD | 13.86% |
| 2021 Q2 | 287.74 Million HKD | 0.0% |
| 2021 Q3 | 267.59 Million HKD | -7.0% |
| 2020 Q1 | 255.87 Million HKD | -13.69% |
| 2020 FY | 252.71 Million HKD | -14.75% |
| 2020 Q2 | 255.87 Million HKD | 0.0% |
| 2020 Q3 | 252.71 Million HKD | -1.23% |
| 2020 Q4 | 252.71 Million HKD | 0.0% |
| 2019 FY | 296.45 Million HKD | 22.27% |
| 2019 Q1 | 307.28 Million HKD | 26.74% |
| 2019 Q2 | 307.28 Million HKD | 0.0% |
| 2019 Q3 | 296.45 Million HKD | -3.53% |
| 2019 Q4 | 296.45 Million HKD | 0.0% |
| 2018 Q2 | 317.56 Million HKD | 0.0% |
| 2018 FY | 242.44 Million HKD | -37.86% |
| 2018 Q3 | 242.44 Million HKD | -23.65% |
| 2018 Q4 | 242.44 Million HKD | 0.0% |
| 2018 Q1 | 317.56 Million HKD | -18.61% |
| 2017 Q4 | 390.18 Million HKD | 0.0% |
| 2017 FY | 390.18 Million HKD | -21.54% |
| 2017 Q3 | 390.18 Million HKD | -14.85% |
| 2017 Q2 | 458.26 Million HKD | 0.0% |
| 2017 Q1 | 458.26 Million HKD | -7.85% |
| 2016 FY | 497.32 Million HKD | -10.71% |
| 2016 Q4 | 497.32 Million HKD | 0.0% |
| 2016 Q3 | 497.32 Million HKD | -5.75% |
| 2016 Q2 | 527.64 Million HKD | 0.0% |
| 2016 Q1 | 527.64 Million HKD | -5.26% |
| 2015 Q4 | 556.95 Million HKD | 0.0% |
| 2015 FY | 556.95 Million HKD | -6.66% |
| 2015 Q3 | 556.95 Million HKD | -6.75% |
| 2015 Q2 | 597.27 Million HKD | 0.0% |
| 2015 Q1 | 597.27 Million HKD | 0.0% |
| 2014 Q3 | 673.85 Million HKD | 0.0% |
| 2014 FY | 596.66 Million HKD | -13.89% |
| 2014 Q1 | 692.91 Million HKD | 0.0% |
| 2013 Q4 | 692.91 Million HKD | -38.99% |
| 2013 FY | 692.91 Million HKD | -20.71% |
| 2013 Q1 | 873.93 Million HKD | 0.0% |
| 2013 Q2 | 1.13 Billion HKD | 29.97% |
| 2013 Q3 | 1.13 Billion HKD | 0.0% |
| 2012 Q1 | 896.69 Million HKD | 0.0% |
| 2012 FY | 873.93 Million HKD | -2.54% |
| 2012 Q2 | 905.48 Million HKD | 0.98% |
| 2012 Q3 | 905.48 Million HKD | 0.0% |
| 2012 Q4 | 873.93 Million HKD | -3.48% |
| 2011 Q1 | 921.83 Million HKD | 0.0% |
| 2011 Q4 | 896.69 Million HKD | -2.29% |
| 2011 FY | 896.69 Million HKD | -2.73% |
| 2011 Q3 | 917.72 Million HKD | 0.0% |
| 2010 Q1 | 1.11 Billion HKD | 0.0% |
| 2010 Q3 | 1.06 Billion HKD | 0.0% |
| 2010 FY | 921.83 Million HKD | -17.02% |
| 2009 FY | 1.11 Billion HKD | -23.26% |
| 2008 FY | 1.44 Billion HKD | -22.42% |
| 2007 FY | 1.86 Billion HKD | 43.6% |
| 2006 FY | 1.29 Billion HKD | 836.14% |
| 2005 FY | 138.8 Million HKD | -24.2% |
| 2004 FY | 183.11 Million HKD | -13.91% |
| 2003 FY | 212.7 Million HKD | 0.35% |
| 2002 FY | 211.96 Million HKD | 18.1% |
| 2001 FY | 179.47 Million HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 96.355% |